WaferGen Bio-systems, Inc.·4

Jan 26, 8:47 PM ET

WaferGen Bio-systems, Inc. 4

4 · WaferGen Bio-systems, Inc. · Filed Jan 26, 2016

Insider Transaction Report

Form 4
Period: 2016-01-22
TRIFUNOVICH IVAN
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2016-01-22+292,345292,345 total
    Exercise: $0.56Exp: 2023-01-22Common Stock (292,345 underlying)
Footnotes (2)
  • [F1]The stock option grant is contingent upon the Issuer's stockholders approving an amendment to the Issuer's 2008 Stock Incentive Plan, as amended (the "Plan") to increase the number of shares issuable under the Plan by at least 2 million. If the Issuer's stockholders do not approve such an amendment on or before June 30, 2016, the stock option shall automatically convert to a cash-settled stock appreciation right that is subject to the same terms and conditions as the stock option.
  • [F2]100% of the shares subject to the option were vested on the grant date

Documents

1 file
  • 4
    wf-form4_145385926608222.xmlPrimary

    FORM 4